Total Funding
4
25
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
184570
NeuroMetrix is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes.
Thomas Higgins: SVP & CFOPast Role: Caliper Life Sciences, Executive Vice President and Chief Financial Officer- Brandi Damkier: Vice President of Clinical Partnerships
electroCore
About the Company
NeuroMetrix is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company currently markets products for the detection, diagnosis, and monitoring of diabetic neuropathies such as diabetic peripheral neuropathy and median neuropathy (carpal tunnel syndrome).
